EGF and chronic obstructive pulmonary disease: Our results, from human muscle and varying in vitro and in vivo experiments using pharmacological and genetic approaches, suggest that increased EGF-EGFR signaling contributes to ST fiber loss in COPD patients and demonstrate that EGFR signaling blockade promotes the development and maintenance of the ST muscle phenotype.